Retrospective Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Jul 26, 2023; 11(21): 5023-5034
Published online Jul 26, 2023. doi: 10.12998/wjcc.v11.i21.5023
Figure 7
Figure 7 Increased level of BIRC5, TRIP13, and UBE2C genes confers cellular resistance to cisplatin in gastric cancer cells. A-C: Colony formation assay in cells with shRNA transfected targeting BIRC5, TRIP13, or UBE2C genes; D-F: Cell apoptosis was detected in BIRC5, TRIP13, and UBE2C knockdown cells after treatment with cisplatin. aP < 0.05; bP < 0.01.